Tags

Type your tag names separated by a space and hit enter

[Malaria--chemoprophylaxis 2001].
Ther Umsch. 2001 Jun; 58(6):347-51.TU

Abstract

An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis.

Authors+Show Affiliations

Departementsleiter Medizin & Diagnostik, Schweizerisches Tropeninstitut, Postfach, CH-4002 Basel. hatz@keep.touch.chNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

ger

PubMed ID

11441694

Citation

Hatz, F R., et al. "[Malaria--chemoprophylaxis 2001]." Therapeutische Umschau. Revue Therapeutique, vol. 58, no. 6, 2001, pp. 347-51.
Hatz FR, Beck B, Blum J, et al. [Malaria--chemoprophylaxis 2001]. Ther Umsch. 2001;58(6):347-51.
Hatz, F. R., Beck, B., Blum, J., Funk, M., Furrer, H., Genton, B., Holzer, B., Loutan, L., Markwalder, K., Raeber, P. A., Schlagenhauf, P., Siegl, G., Steffen, R., Stürchler, D., & Wyss, R. (2001). [Malaria--chemoprophylaxis 2001]. Therapeutische Umschau. Revue Therapeutique, 58(6), 347-51.
Hatz FR, et al. [Malaria--chemoprophylaxis 2001]. Ther Umsch. 2001;58(6):347-51. PubMed PMID: 11441694.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Malaria--chemoprophylaxis 2001]. AU - Hatz,F R, AU - Beck,B, AU - Blum,J, AU - Funk,M, AU - Furrer,H, AU - Genton,B, AU - Holzer,B, AU - Loutan,L, AU - Markwalder,K, AU - Raeber,P A, AU - Schlagenhauf,P, AU - Siegl,G, AU - Steffen,R, AU - Stürchler,D, AU - Wyss,R, PY - 2001/7/10/pubmed PY - 2001/8/31/medline PY - 2001/7/10/entrez SP - 347 EP - 51 JF - Therapeutische Umschau. Revue therapeutique JO - Ther Umsch VL - 58 IS - 6 N2 - An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis. SN - 0040-5930 UR - https://www.unboundmedicine.com/medline/citation/11441694/[Malaria__chemoprophylaxis_2001]_ L2 - https://econtent.hogrefe.com/doi/10.1024/0040-5930.58.6.347?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -